Viewing Study NCT00068666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT00068666
Status: TERMINATED
Last Update Posted: 2016-12-15
First Post: 2003-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV melanoma View
None recurrent melanoma View
None tumors metastatic to brain View